Takeda Pharmaceutical (TAK) Total Debt: 2018-2025

Historic Total Debt for Takeda Pharmaceutical (TAK) over the last 8 years, with Mar 2025 value amounting to $29.6 billion.

  • Takeda Pharmaceutical's Total Debt fell 9.45% to $29.6 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $29.6 billion, marking a year-over-year decrease of 9.45%. This contributed to the annual value of $29.6 billion for FY2025, which is 11.75% down from last year.
  • According to the latest figures from FY2025, Takeda Pharmaceutical's Total Debt is $29.6 billion, which was down 11.75% from $33.6 billion recorded in FY2024.
  • Takeda Pharmaceutical's Total Debt's 5-year high stood at $45.9 billion during FY2021, with a 5-year trough of $29.6 billion in FY2025.
  • Over the past 3 years, Takeda Pharmaceutical's median Total Debt value was $32.4 billion (recorded in 2023), while the average stood at $31.9 billion.
  • As far as peak fluctuations go, Takeda Pharmaceutical's Total Debt dropped by 16.19% in 2023, and later increased by 3.54% in 2024.
  • Over the past 5 years, Takeda Pharmaceutical's Total Debt (Yearly) stood at $45.9 billion in 2021, then declined by 15.60% to $38.7 billion in 2022, then declined by 16.19% to $32.4 billion in 2023, then rose by 3.54% to $33.6 billion in 2024, then fell by 11.75% to $29.6 billion in 2025.